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ABSTRACT 
Cell-based therapies have great potential for the treatment of cardiovascular diseases. 
Recently, using a transgenic mouse model Roell et al. reported that cardiac 
engraftment of connexin43-overexpressing myoblasts in vivo prevents post-infarct 
arrhythmia, a common cause of death in patients following heart attack [Nature 2007; 
450: 819-24]. We carried out a similar study but in a clinically relevant context via 
transplantation of autologous connexin43-overexpressing myoblasts in infarcted rats. 
Seven days after coronary ligation, rats were randomized into 3 groups: a Control 
group injected with myoblasts, a Null group injected with myoblasts transduced with 
an empty lentivirus vector (Null), and a Cx43 group injected with myoblasts 
transduced with a lentivirus vector encoding connexin43. In contrast to Roell’s report, 
arrhythmia occurrence was not statistically different between groups (58%, 64% and 
48% for the Control (n=12), Null (n= 14) and Cx43 (n=23) -groups, respectively, 
p=0.92). Using ex vivo intramural monophasic action potential recordings synchronous 
electrical activity was observed between connexin43-overexpressing myoblasts and 
host cardiomyocytes, whereas such synchrony did not occur in the Null-transduced 
group. This suggests that ex vivo connexin43 gene transfer and expression in 
myoblasts improved intercellular electrical coupling between myoblasts and 
cardiomyocytes. However, in our model such electrical coupling was not sufficient to 
decrease arrhythmia induction. Therefore, we would suggest a note of caution on the 
use of combined Cx43 gene and cell therapy to prevent post-infarct arrhythmias in 
heart failure patients. 
 Keywords: cell therapy, gene therapy, arrhythmia, connexin43, myoblast 
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INTRODUCTION 
 
The hypothesis behind cell-based therapy for cardiac injury is that adding healthy cells 
to injured myocardium increases the rate of recovery and, in so doing, improves 
cardiac function and prevents life-threatening arrhythmias, the major cause of sudden 
death in heart failure patients. Yet, to date, success with cell therapies has been 
limited, and under some conditions, such therapy results in arrhythmias, a documented 
risk of skeletal muscle myoblast delivery into the heart[1]. The exact mechanism of 
these arrhythmias is unknown, but it has been suggested that they result from a lack of 
electrical coupling between the skeletal myoblasts and the host cardiomyocytes[2]. 
Electrical coupling between ventricular cardiomyocytes is very efficient in healthy 
myocardium, and depends mainly on Connexin43 expression (Cx43, the primary 
ventricular gap junction protein). Interestingly, proliferating myoblasts express Cx43 
but down-regulate Cx43 expression progressively upon fusion, mature skeletal 
myofiber (myotube) formation and further differentiation. Several preclinical and 
clinical studies have shown that once injected into the heart, myoblasts differentiate 
into myotubes, and thus, are not coupled to neighboring cardiomyocytes[3,4]. 
Interestingly, transplanted myotubes are able to contract spontaneously occasionally, 
but these contractions do not spread to neighboring cardiomyocytes[2]. In vitro and 
ex vivo studies have shown that a mixture of myotubes and cardiomyocytes without 
sufficient functional gap junctions results in slower conduction velocities and greater 
tissue heterogeneity[5,6]. Such heterogeneity predisposes to wave breaks and reentry, 
both key elements for inducing ventricular arrhythmias[7]. 
Recently, in a well-designed study using an in vivo infarcted mouse model, Roell et al. 
showed that cardiac transplantation of myoblasts from transgenic mice overexpressing 
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connexin43 (Cx43, the main cardiac gap junction protein) not only eliminates 
myoblast pro-arrhythmogenic effect but also provides potent protection against 
ventricular arrhythmias[8]. They concluded that an increase in intercellular coupling 
by cell-based therapy may be an effective therapy to prevent post-infarction 
ventricular arrhythmias[8]. 
In a previous study[9], we transplanted autologous myoblasts or autologous bone 
marrow cells into infarcted heart of Wistar rats. Like Roell et al, using in vivo 
programmed electrical stimulation (PES), we showed that transplantation of myoblasts 
but not of bone marrow mononuclear cells increases arrhythmia induction. As a follow 
up, the purpose of this new study was to evaluate arrhythmogenicity after autologous 
cell therapy and Cx43 ex vivo gene transfer. This combination of cells and genes 
represents a clinically relevant and pragmatic approach to Roell’s hypothesis. Despite 
electrical coupling between transplanted cells and host cardiomyocytes (as 
demonstrated by Roell and confirmed in our study), we did not observe any reduction 
in post-infarct arrhythmias.  
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MATERIALS AND METHODS 
 
Experimental model  
All animal experiments were performed in accordance with the Guide for the Care and 
Use of Laboratory Animals published by the US National Institute of Health (NIH 
Publication No. 85-23, revised 1996). 
Autologous myoblasts were injected into the infarcted area of the myocardium of 
Wistar rats 7 days after coronary ligation. As previously described, intramyocardial 
injections of a total of 10.106 autologous myoblasts were performed under direct 
observation via left thoracotomy[9]. Myoblast primary cultures were sourced from 
tibialis anterior muscles of male Wistar rats as previously described[9,10]. 
 
Lentivirus vector construction and production 
A self-inactivating HIV-derived gene-transfer plasmid (pHR’-CMV-Cx43-W-sin18; 
Figure Ia) containing the cDNA for rat Cx43 downstream of the cytomegalovirus 
(CMV) promoter elements was kindly provided by Pr P. Meda (University of Geneva, 
Switzerland). As controls we used a lentivirus vector containing the same expression 
cassette but without the Cx43 cDNA (Null) or a lentivirus vector containing the same 
expression cassette and the Green Fluorescent Protein (GFP) cDNA. Lentivirus vector 
production was performed by the LentiVirus Production Unit (LVPU, Geneva, 
Switzerland). 
 
Lentivirus vector transduction 
Transduction was carried out by adding lentivirus vector to myoblast primary culture 
24 hr after cell isolation (40 transducing units (TUs) /cell). Transduced cells were 
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cultured in vitro for 6 days before intramyocardial transplantation. Non-transduced 
myoblasts and Null-transduced myoblasts served as controls.  
 
FACS analyses 
Quantification of myoblasts and of lentivirus vector transduction efficacy in primary 
culture was performed using desmin (a specific marker for muscle cells) and GFP 
expression, respectively, in flow cytometry analyses. A mouse anti-human desmin 
antibody (D33, Dako-Cytomation, Denmark), and a second fluorescent antibody (alexa 
red anti mouse IgG; Molecular Probes) were used to detect desmin. For all GFP 
analyses thresholds were chosen using a cell sample from the same primary culture 
that has not been transduced with GFP-lentivirus and that did not undergo desmin 
immunolabeling. Analyzes were performed using a FACSCalibur instrument (BD 
Biosciences, San Jose CA, CellQuestPro software). 
 
RNA isolation 
Total RNA was isolated from myoblasts and from myocardial tissue injected with 
myoblasts, using a RNeasy Mini kit (QIAGEN) and a RNeasy fibrous tissue Mini kit 
(QIAGEN), respectively. DNase treatment was performed after each RNA extraction 
to eliminate genomic DNA (RNase free DNase set; QIAGEN). Absence of RNA 
degradation was verified by capillary electrophoresis on a 2100 Bioanalyser (Agilent).  
 
Real time RT-PCR 
First-strand cDNA was synthesized from 2 µg of total RNA using the High-Capacity 
cDNA Archive Kit (Applied Biosystems) and was preamplified using 
TaqMan®PreAmp Master Mix Kit (Applied Biosystems). On-line PCR was performed 
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with the following primers: desmin (Rn00574732_m1), and Cx43 (Rn01433957_m1). 
Fluorogenic TaqMan probes were labeled on the 5’-end with the fluorescent reporter 
dye 6-carboxyfluorescein (FAM®, Applera), and on the 3’-end with non-fluorescent 
quencher (Applied Biosystems). Data were collected with instrument spectral 
compensations by the Applied Biosystems SDS 2.3 software and analyzed using the 
threshold cycle (CT) relative quantification method. Fluorescence levels were 
normalized to the hypoxanthine guanine phosphoribosyl transferase (HPRT, 
Rn01527838_g1), used as reference gene. Specific mRNA quantifications were 
performed in duplicate. Absence of DNA contamination in RNA samples was verified 
by performing real time PCR on RNA samples that were not reverse transcribed. All 
data were averaged and then used for the 2-∆CT calculation. 2-∆CT corresponds to the 
ratio of each gene expression versus HPRT.  
 
Immunolabeling 
Serial cryosections (10µm) were performed 2 weeks after myoblast transplantation. A 
mouse monoclonal antibody against the fast skeletal myosin heavy chain (clone My32, 
NCL-MHCf, Novocastra) and a rabbit polyclonal antibody against Cx43 (Zymed 
Laboratories, USA) were used for identification of differentiated myotubes and Cx43, 
respectively.  
 
Ex vivo intramural electrophysiologic recordings 
Animals were sacrificed 2 weeks after autologous myoblast transplantation by 
pentobarbital injection (100mg/kg ip; Pentobarbital sodique®, Cerva Santé Animale). 
After heparin injection (3750 UI/kg ip; Héparine Choay), hearts were harvested for 
Langendorff perfusion at 37°C with a Krebs modified solution (NaCl, 118.3 mM; 
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KCl, 3.8 mM; MgSO4, 1.2 mM; NaHCO3, 25 mM; KH2PO4, 1.2 mM; 
glucose, 11.1 mM; CaCl2, 1.25 mM), saturated with carbogen (O2 95% and CO2 5%). 
Monophasic action potentials (MAPs) were recorded during sinus rhythm (250ms) at 
different sites of the myocardium (in the healthy myocardium, in the infarct border 
zone and in the transplanted area of the infarct). These different sites were probed 
serially with a single MAP sharp, tungsten needle-electrode that was isolated except at 
the tip, as previously described [11]. Recordings in the tibialis muscle were performed 
in situ from a nerve/tibialis muscle preparation. The nerve was stimulated and the 
same MAP-electode was inserted in the tibialis. Trains of 1 ms stimuli (S1-S1 250ms) 
were applied to the nerve and the MAPs were recorded. Because the nerve was 
stimulated, no pacing artifacts were present. Because the tip was in the extracellular 
space, it also recorded extracellular potentials [12]. 
 
In vivo programmed electrical stimulation 
Ventricular electrical instability related to cell transplantation was evaluated in all 
groups using the PES procedure, as described previously[9]. Briefly, an epicardial 
electrode was tied to the viable left ventricular myocardium during surgery for 
coronary ligation. For PES stimulation, animals were sedated with etomidate 
(8 mg/kg ip; Hypnomidate®, Janssen-Cilag) and pentobarbital (40 mg/kg ip). The distal 
tip of the epicardial electrode was externalized to be used as the negative lead. Another 
electrode was placed on the thorax to be used as the positive lead, allowing unipolar 
stimulation (UHS 20, Biotronik). Surface six-lead ECGs were recorded for monitoring 
and later analyses. Standard criteria were used for interval measurements (RR, PR, 
QRS and QT). For further comparison between groups, QT interval were corrected 
using bot Fredericia and Bazett fomulas (QTc(F) = QT/ (RR/150)1/3and QTc(F) = QT/ 
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(RR/150)1/2 respectively; Table I). Standard clinical PES protocols were used, 
including single, double and triple extrastimuli applied under spontaneous rhythm or 
following a train of 9 stimuli at 100-ms drive cycle length. The coupling interval of the 
last extrastimulus was decreased to the ventricular effective refractory period (VERP). 
Protocols were interrupted if sustained ventricular tachycardia (VT) was induced. 
Sustained VT was defined as fast ventricular rhythm of 15 or more beats, according to 
the Lambeth Conventions[13]. 
 
Data Analyses 
Data were expressed as mean±SEM and frequencies (expressed as percentages). 
Statistical analyses were performed using MedCalc 9.1 software. Real time RT-PCR 
data and cell count data were assessed using the Student t-test. Occurrences of 
sustained VT were compared with Cox’s model and were analyzed as failure time data 
(rats without event were considered as censored). The assumption of proportional 
hazards between groups was confirmed, and the group was the unique covariate 
selected in the Cox’s model. Overall mortality between groups was compared using 
Fisher’s exact test. ECG parameters (P, RR, PR, QRS, QT and QTc and VERP values) 
were assessed by a linear mixed model with random slope and intercept in the control, 
Null, and Cx43 groups. The fixed effects were the group and the time. Interaction 
between group and time was tested but not included in the model (not significant). The 
power of the study was 0.40 for all statistical analysis. A p-value <0.05 was considered 
significant.  
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RESULTS 
In vitro Cx43 overexpression  
A lentivirus vector was used to overexpress Cx43 in rat myoblast primary cultures 
ex vivo, prior to autologous intramyocardial injection (Figure 1a). As controls we used 
lentivirus vectors containing an empty expression cassette (Null) or the Green 
Fluorescent Protein (GFP) cDNA. Efficacy of lentivirus transduction was evaluated 
in vitro using flow cytometry analyses for both GFP and desmin after GFP lentivirus 
vector transduction. GFP was expressed by 50% of the desmin positive cells, 
suggesting that 50% myoblasts expressed the transgene before transplantation (Figure 
1b). The transduction rate of non-myoblast contaminating cells (i.e. GFP+ desmin – 
cells) was 16.3±4.1% (Figure 1b). Seven days after Cx43 or Null lentivirus 
transduction, cell counts and desmin expression levels were similar in both Null- and 
Cx43-transduced myoblasts, whereas Cx43 expression level was 2.5 fold higher in 
Cx43- than in Null-transduced myoblasts (p<0.05), showing that Cx43 overexpression 
did not alter myoblast expansion (Figure 2a).  
To evaluate exogenous Cx43 expression due to Cx43 lentivirus vector transduction, we 
used gene expression quantification of the post-transcriptional regulatory element 
Woodchuck hepatitis virus (Wpre), that is located within the expression cassette of the 
lentivirus vector in 3’ of the Cx43 cDNA and proximal to the polyadenylation signal 
(Figure 1a). Wpre gene expression was detected only in Cx43-transduced myoblasts 
6 days after Cx43- and Null-transduction (Figure 2b). In Cx43-transduced myoblasts, 
total Cx43 gene expression level correlated with Wpre expression level (R2=0.8710; 
Figure 2b). Finally, in vitro time-course studies demonstrated that Cx43 expression 
remained at least 2.5 fold higher in Cx43-transduced myoblasts than in Null-
transduced myoblasts (p<0.05, Figure 2c) for at least 35 days after Cx43 transduction. 
Page 10 of 32Journal of Cellular and Molecular Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 11 
Moreover, in Cx43-transduced myoblasts, Wpre gene expression remained stable. In 
view of these results, Wpre was used as a marker to detect exogenous Cx43 expression 
in vivo after intramyocardial myoblast transplantation.  
 
In vivo Cx43 overexpression  
Seven days after coronary ligation, rats were randomized into 3 groups: a Control 
group injected with autologous myoblasts, a Null group injected with autologous 
myoblasts transduced with the Null lentivirus vector, and a Cx43 group injected with 
autologous myoblasts transduced with the lentivirus vector encoding Cx43.  
Using real time RT-PCR, Wpre gene expression was detected in 9/9 hearts injected 
with Cx43-tranduced myoblasts up to 35 days after their in vivo injection (Figure  3a), 
suggesting that Cx43-transduced muscle cells overexpressed Cx43 in vivo. Two weeks 
after Cx43-transduced myoblast transplantation, Cx43 protein was detected in 
cryosections of infarcted myocardium in cells expressing fast skeletal myosin heavy 
chain (Figures 3b-h), suggesting that ex vivo Cx43 lentivirus vector transduction lead 
to in vivo Cx43 protein expression in differentiated myotubes.  
 
Electrophysiological analyses 
PES was performed at 1, 2, 3 and 4 weeks after intramyocardial myoblast 
transplantation. No differences between groups were observed in ECG parameters 
prior to the first PES procedure (week 1). Neither standard ECG measurements nor 
VERP at 100-ms pacing cycle length were significantly altered by the repeated PES 
procedures (Table I), suggesting that lentivirus vector transduction (in Null group) or 
Cx43 overexpression (in Cx43 group) in transplanted myoblasts did not modify ECG 
parameters. Overall the percentage of rats that underwent at least one arrhythmia event 
Page 11 of 32 Journal of Cellular and Molecular Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 12 
during one of the PES were similar between groups (58%, 64% and 48% of animals in 
the Control (n=12), Null (n=14) or Cx43 (n=23) group, respectively, Cox’s model, 
p=0.92, Figure 4a). Additionally, the percentage of newly inducible rats did not differ 
among groups (Figure 4b). In each group, ECG parameters of rats that underwent 
sustained VT during PES did not differ from those that did not show sustained VT (not 
illustrated). Mortality was similar in Control, Null or Cx43 groups (42%, 50%, 43%, 
respectively, p=0.87). 
 
Ex vivo measurements of intramural monophasic action potentials (MAPs) 
To evaluate electrical coupling between Cx43-overexpressing myoblasts and host 
cardiomyocytes, ex vivo intramural monophasic action potential (MAP) recordings 
were performed 14 days after myoblast injection in Langendorff-perfused hearts, using 
a tungsten electrode that recorded both local MAP and remote electrical activity. For 
each rat, MAPs were recorded during sinus rhythm at 7 different sites (1 located in the 
right ventricle and 6 located in the left ventricle). Control included recordings from rat 
tibialis muscle (Figure 5a) and from healthy non-infarcted myocardium (Figure 5b). A 
total of 16 rats were evaluated, 6 in the Cx43 and in the Null groups, and 4 in the 
Control group. Recordings in the infarct solely showed the remote signal of healthy 
myocardium in both Null and Cx43 groups in 9/16 animals (Figures 5c,d). In 5/16 rats 
monophasic action potentials (MAPs) were recorded with average duration of 
52.9±4.6ms, while in 2/16 rats significantly shorter MAPs were recorded of 2.8±1.9ms 
(p<0.001, Figures 5e,f, and Figures 5h,i (asterisks)). These short MAPs were similar to 
those recorded in rat tibialis muscle (MAP duration 3.5ms, Figure 5a,g), while the 
longer MAPs recorded in the infarct compared well to MAPs recorded in healthy 
cardiac muscle (MAP duration 55.1±2.4ms, p=0.96, n=16). No such short MAPs were 
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recorded in the non-transplanted area of the heart, strongly suggesting that the short 
MAPs reflected electrical activity of transplanted skeletal muscle cells, while the 
longer MAPs reflected electrical activity of host cardiomyocytes. 
In myocardium transplanted with Null-transduced myoblasts, skeletal muscle cell 
MAPs and myocardial electrograms were not synchronized (Figures 5e,h), suggesting 
that skeletal muscle cells were not activated in synchrony with host cardiomyocytes. In 
contrast, in left ventricle from the Cx43 group, skeletal muscle cells exhibited 
electrical activity in synchrony with surrounding healthy myocardium (Figures 5f,i). 
Multiple registrations of 2 seconds of myoblast spikes were performed from the same 
location in these rats. In the Null group, the mean interval for myoblast spikes was 545 
ms (range 541 – 549 ms) and for myocyte spikes was 224 ms (range 214 – 233). In the 
Cx43 group, the mean interval for myoblast spikes was 225 ms. Myoblast spikes were 
synchronous with myocyte activity. These results suggest that ex vivo Cx43 gene 
transfer and expression in myoblasts enhanced electrical coupling and frequency 
entrainment of skeletal muscle cells and host cardiomyocytes.  
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DISCUSSION 
In this study, using an in vivo model of cardiac cell and gene therapy with autologous 
myoblasts (in which arrhythmic risk related to myoblast transplantation has been 
previously evaluated[9]), ex vivo Cx43 gene transfer prior to intramyocardial 
transplantation enhances Cx43 expression and in vivo electrical coupling between 
transplanted myoblasts and host cardiomyocytes. However, in our model, improved 
electrical coupling was not sufficient to significantly decrease arrhythmogenicity 
related to myoblast transplantation. 
Several in vitro studies showed that in myoblast/cardiomyocyte coculture models, 
lentiviral-mediated overexpression of Cx43 in myoblasts was sufficient to induce gap 
junction formation between both cell types[5,14-16]. Although we did not demonstrate 
gap junction formation in the present study, the functionality of these gap junctions 
was demonstrated by others, using western blot analyses and in vitro dye transfer 
techniques[5,15,16]. In our study, gap junction formation and functionality were 
suggested in vivo by electrical coupling between skeletal muscle cells and 
cardiomyocytes that occurred only in myocardium injected with Cx43-transduced 
myoblasts. Cx43 overexpression in myoblasts and gap junction formation have also 
been successfully obtained using retrovirus[15] or adenovirus[17] vectors. In contrast 
with our present study, increased cell death was observed in vivo after Cx43 
adenovirus vector transduction and cell transplantation[17]. This was clearly linked to 
very high vector transduction rate, as usually obtained with adenovirus vectors[18] in 
contrast to retrovirus or lentivirus vectors. In our study, 50% myoblasts were 
transduced by the lentivirus vectors, and Cx43 expression increased only 2.5-fold as 
compared to baseline levels, a level compatible with studies using similar gene transfer 
conditions[15]. In one study, no Cx43 overexpression was observed after cell 
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transplantation of Cx43 retrovirus vector-transduced myoblasts, an observation that 
was linked to promoter silencing[15]. In our study, this was clearly not the case since 
Wpre, a regulatory element within the expression cassette, was expressed in vivo more 
than 8 weeks after cell transplantation. In summary, although each vector type lead 
in vitro to significant Cx43 overexpression and gap junction formation, lentivirus 
vector transduction offered long in vivo expression without deleterious effects. 
An in vitro study showed an increase in electrical coupling between cardiomyocytes 
and myoblasts transduced with a lentivirus vector encoding Cx43 associated to a 
reduction (but not elimination) of myoblast arrhythmogenicity[5], an hypothesis that 
needed to be evaluated in vivo. Both Roell’s study and ours provided evidence of 
in vivo host cardiomyocyte and transplanted myoblast electrical coupling when 
myoblasts overexpressed Cx43. In this regard, our results confirm the feasibility of 
ex vivo gene transfer to modify in vivo electrophysiological properties of injected 
cells[19]. The rat number in which myoblast MAPs were observed in the heart was 
very low, most probably because MAP recordings were performed each time using one 
single electrode and that this electrode recorded only local electrical activity. 
Therefore the chance that the electrode was placed in close proximity with myoblasts 
was low, as myoblast number was also probably low. Furthermore, myoblast spikes 
might have been hidden in the upstroke of myocyte MAPs. Some myocyte MAPs in the 
Cx43 group showed fractionated upstrokes (not shown), suggesting that myoblast 
spikes caused fractionation of the upstroke of these myocyte MAPs. Nevertheless, 
fractionated upstrokes were not counted, since there was no final proof that these 
deflections were indeed myoblast spikes. MAP recordings were performed at a pacing 
cycle length of 250 ms. This cycle length was chosen because this is the rat normal 
spontaneous sinus cycle length. Evaluating the level of electrical coupling between 
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transduced myoblasts and cardiomyocytes in vivo was not possible by changing pacing 
rate. Conduction is determined by 3 parameters (excitability, cell-to-cell coupling and 
myocardial architecture), and it is not possible to determine the contribution of a 
single parameter by changing stimulation frequency. In addition, in remodeled 
infarcted myocardium, all three parameters are changed. If conduction delay increased 
between myoblasts and cardiomyocytes at a higher stimulation frequency it is unclear 
whether this would be due to an inadequate coupling between host and donor cells, a 
reduced coupling between cardiomyocytes, impaired sodium current of the 
cardiomyocytes or the changed myocardial architecture.  
In contrast to Roell’s study, electrical coupling was not sufficient to significantly 
decrease arrhythmogenicity related to myoblast transplantation in a clinically relevant 
model combining gene and autologous cell therapy. This result highlights the 
differences between the in vivo study by Roell et al and ours, including the animal 
model and the level of Cx43 overexpression in transplanted cells. Although the type of 
injury may have an impact on arrhythmia triggering, arrhythmias associated to cell 
therapy were evaluated in different models of myocardial injury (cryolesion[8], 
ischemia/reperfusion[20] or even pharmacological models[21]. This suggests that 
myoblast-induced arrhythmias are not dependent from the myocardial infarction 
model. As in Roell’s study, we did not evaluate spontaneous ventricular 
tachyarrhythmias, because their frequency is low in rodents[9]. Although in Roell’s 
study VT frequency was 100% in the myocardial infarction model, VT frequency was 
60% in ours (a result similar to that of our previous study, confirming the 
reproducibility of our model), probably because we counted only VT>15 beats. 
Although we did not measure the extent of myocardial infarction in the present study, 
histological analysis of the same model in our previous study showed a reproducible 
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scar of 25+3% of the left ventricle 7 weeks after coronary ligation[9], an infarct size 
comparable to that in other studies using the same animal model[22]. Finally, as 
mentioned above in our study only 50% transduced myoblasts expressed Cx43, 
inducing an increase of the overall Cx43 expression only 2.5 fold as compared to 
baseline levels. Because Roell et al. used myoblasts from a genetically modified 
mouse overexpressing Cx43, both percentage of Cx43-overexpressing myoblasts and 
Cx43 expression level may have been significantly higher, favoring extensive 
electrical coupling between myoblasts and cardiomyocytes. Importantly, only 
frequency but not waveform entrainment (typical for low coupling between cells with 
different intrinsic action potential waveforms) was observed in our study, suggesting 
that electrical coupling was too low to significantly affect the electrical stability of the 
heart. It has also been suggested that the occurrence of arrhythmias depends on cell 
distribution within the infarcted area, an hypothesis that was not confirmed in a recent 
study on rabbits[23]. Notably, in the transgenic mouse study, electrical stability 
occurred even in animals whose stem cell grafts were physically isolated from the 
native myocardium. Finally, because myoblasts do not transdifferentiate into 
cardiomyocytes and because their action potential duration remains significantly 
shorter than host cardiomyocytes[24], an electrical coupling between both cell types 
might induce locally heterogeneous distribution of action potential duration, another 
risk factor for arrhythmia[1]. Although this potential adverse effect has not been 
detected in vitro or in rodent models, because early preclinical studies did not reveal 
the tendency of myoblasts to induce life-threatening arrhythmias such hypothesis 
needs to be evaluated in larger animal models.  
Our study has some limitations. First, we did not correlate the injected-cell number 
with arrhythmia inducibility, and Cx43 overexpression might have increased in vivo 
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cell engraftment and/or proliferation as compared to engraftment of Null-transduced 
cells. Although a dose-dependence between cell engraftment rate and arrhythmia might 
be expected, results of a recent randomized double-blind clinical trial did not support a 
dose-response increase in arrhythmic episodes[25]. In our study, we did not evaluate 
the level of myoblast contamination with smooth muscle cells nor their level of viral 
infection with Cx43 transgene. In humans and in rats, myoblast primary culture from 
muscle samples does not lead to pure myoblast preparations[10, 3, 26], the culture 
being contaminated mostly with fibroblasts. In Roell’s study, myofibroblasts induced 
arrhythmias, suggesting that if myofibroblasts contaminated myoblast culture, they 
may induce arrhythmia when injected in vivo. Therefore we cannot rule out the 
contribution to arrhythmia triggering of transduced or untransduced contaminating 
cells with Cx43 lentivirus vector. In Roell’s study, Cx43 was expressed under the 
control of a promoter specific for myotubes. Therefore contaminating smooth muscle 
cells did not overexpress Cx43 in Roell’s study. Nevertheless, there was a significant 
decrease in arrhythmias following injection of Cx43-overexpressing myoblasts, 
suggesting that contaminating cells within myoblast preparations did not play a major 
role in arrhythmias.  
Finally, improvement of the heart function after myoblast transplantation was not 
studied. Myoblast transplantation in the failing heart has been initially motivated by 
the hope that transplanted cells would actively improve systolic contraction. It has 
been shown that myoblasts could organize in fibers with contractile capacity, with the 
right orientation such that their synchronous contraction would increase the heart 
contraction strength. Without electrical coupling, skeletal muscle cells are incapable of 
contributing to contraction. Myoblasts have been shown to improve heart function 
(possibly by paracrine effect), and one important question would be to evaluate if an 
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enhanced electrical coupling (leading to synchronous contraction) improves efficacy of 
myoblast therapy[24].  
Although Cx43 expression level in Cx43 lentivirus vector-transduced myoblasts was 
compatible with in vitro studies using similar gene transfer conditions[5], it may be 
ineffective to restore full electromechanical coupling in an injured heart, as expression 
of other junction proteins such as N-cadherin may also be necessary[27]. Therefore, 
based on our present electrophysiological study we would suggest a note of caution on 
the use of combined gene and cell therapy to prevent post-infarct arrhythmias. Current 
technologic limitations to gene therapy, including low gene transduction and low 
foreign gene expression may explain these results. In this regard, further studies to 
improve gene therapy vectors will be rewarding. 
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Tables 
 
 
Table I: ECG parameters and VERP values 
 
 
 
 
 
 
 
 
ECG measurements were performed under sinus rhythm. Ventricular Effective 
Refractory Period was measured at a basic pacing cycle length (BCL) of 100ms at 
week 1, 2, 3 and 4 after myoblast transplantation. Abbreviations: P, P wave duration; 
RR, PR, QRS, QT, QTc(B) and QTc(F): RR, PR, QRS, QT intervals, QT interval 
corrected with Bazett formula (B) or Fredericia formula (F) respectively; VERP, 
Ventricular effective refractory period. All measurements were performed on lead I 
under general anesthesia. Results are expressed as mean±SEM. 
Groups ECG parameters (ms)
RR P PR QRS QT
Week 1 154±3.9 19±0.6 48±0.7 21±0.9 84±3.9
158±3.6 19±0.5 50±1.6 21±0.7 83±2.8
156±2.9 18±0.3 48±1.5 22±1.2 84±1.7
Week 2 151±4.0 20±0.7 49±0.9 21±0.8 86±3.0
158±4.4 19±0.5 50±1.9 21±0.5 86±2.9
150±2.3 18±0.3 48±1.0 20±0.6 80±1.5
150±2.6 18±0.6 47±0.9 21±0.8 84±2.1
152±3.4 18±0.5 48±1.3 21±0.5 84±1.9
149±2.8 18±0.4 48±1.0 21±0.7 80±2.2
152±2.2 19±0.5 49±1.7 19±1.3 85±2.3
157±4.6 20±0.4 50±1.5 22±0.7 84±1.8
149±3.9 18±0.5 48±1.1 21±0.8 83±1.6
VERP
69±3.2
65±3.5
59±1.7
59±2.9
65±5.6
62±3.5
68±3.4
59±4.6
60±2.4
61±2.1
52±3.6
61±2.4
83±2.4
81±2.2
83±1.2
85±2.3
84±2.5
80±1.8
84±1.6
83±1.6
80±2.3
86±2.2
83±1.5
83±1.2
84±25
82±2.2
84±1.3
86±2.3
85±2.6
80±1.7
84±1.7
84±1.6
80±2.2
86±2.3
83±1.5
83±1.3
QTc (B) QTc (F)
Time
Week 3
Week 4
Control (n=14)
Null (n=12)
Cx43 (n=23)
Control (n=12)
Null (n=12)
Cx43 (n=21)
Control (n=9)
Null (n=9)
Cx43 (n=17)
Control (n=7)
Null (n=7)
Cx43 (n=13)
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Figure legends 
 
Figure 1: Cx43 transgene expression in myoblasts.  
(a) The Cx43 lentivirus vector contained an expression cassette including the rat Cx43 
cDNA under the control of the cytomegalovirus (CMV) promoter, followed by the 
post-transcriptional regulatory element of the woodchuck hepatitis virus (Wpre). (b) 
Evaluation of lentivirus vector transduction in myoblast primary culture 6 days after 
GFP-lentivirus vector transduction, by flow cytometry analyses: cells from primary 
culture that have not been transduced with GFP lentivirus and that have not been 
labeled for desmin were used as controls to design thresholds (non-transduced 
cells/Des-; top left panel). The same thresholds were further used for FACS analyses 
of non-transduced cells/Des+ cells (non-transduced cells with desmin immunostaining; 
top right panel), of GFP-transduced/Des- cells (GFP-transduced cells with no 
immunostaining; bottom left panel) and of GFP-transduced/Des+ cells (GFP-
transduced cells with desmin immunostaining; bottom right panel).  
 
Figure 2: Characterization of myoblast primary cultures after lentivirus vector 
transduction. 
 (a) Cell numbers (left panel) and desmin or Cx43 mRNA levels (right panel) in Null- 
and Cx43-transduced myoblasts (n=10 and n=9, respectively), 6 days after lentivirus 
vector transduction. Gene expression levels were measured using TaqMan real time 
RT-PCR. Desmin and Cx43 gene expression levels were corrected by HPRT gene 
expression levels. (b) Correlation between Cx43 and Wpre mRNA expression levels in 
Cx43 transduced myoblasts, 6 days after lentivirus vector transduction (n=9). (c) Cx43 
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gene expression from day 14 to day 35 post-transduction in Null- (dotted line) and 
Cx43- transduced myoblasts (solid line, n=3 for both groups). * indicate p<0.05. 
 
Figure 3: In vivo Cx43 and Wpre gene expression, following ex vivo lentivirus 
vector transduction and intramyocardial transplantation. 
 (a) Wpre expression in myocardium transplanted with Cx43 transduced myoblasts. (b-
h) Section of left ventricle transplanted with Cx43-transduced myoblasts, in 
fluorescent microscopy (b to e) and in confocal microscopy (f to h), using 
immunolabeling against the fast skeletal myosin heavy chain (b and f) and Cx43 (c and 
g). Cell nuclei were labeled with DAPI (d). (e) Superposition of the b-d panels. (h) 
Superposition of the f and g panels. Cryosections were performed within the infarcted 
area, 14 days after myoblast transplantation.  
 
Figure 4: Ventricular hyperexcitability of the myocardium after myoblast 
transplantation. Rats with myocardial infarction underwent in vivo Programmed 
Electrical Stimulation (PES) procedures at 1, 2, 3 and 4 weeks after myoblast 
transplantation. (a) Percentage of Control, Null and Cx43 rats with at least one episode 
of sustained ventricular tachycardia (VT) during one of the PES procedures (p=0.92, 
Cox’s model). (b) Percentage of rats with first episode of sustained VT between week 
1 and 4 after myoblast transplantation. 
 
Figure 5: Ex vivo intramural electrophysiological recordings. Recordings were 
performed using a sharp, tungsten needle electrode that recorded both local 
Monophasic Action Potentials (MAPs) and remote electrograms. (a) MAPs from rat 
tibialis anterior muscle (paced at 250-ms intervals); stars indicate fast spikes of 5 to 
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10ms length, typical for skeletal muscle. (b) MAPs from healthy myocardium in the 
left ventricular free wall. Diamonds indicate typical rat cardiac MAPs of 80ms 
duration. (c,d) Electrograms within the infarcted myocardium area (triangles), 14 days 
after intramyocardial transplantation of Null-transduced myoblasts (c) or of Cx43-
transduced myoblasts (d). The MAP-needle only recorded the electrograms of remote 
ventricular activity, as indicated by the triangles. (e,f) MAPs and electrograms from 
the same infarcted regions as in c and d, but in the transplanted area. Asterisks and 
triangles indicate MAPs from skeletal muscle cells and electrograms from remote non-
infarcted myocardium, respectively. Note the synchrony between MAPs from skeletal 
muscle cells (asterisks) and ventricular electrograms (triangles) in the Cx43 group. 
The extracellular complex (triangle) in tracing f was remote. The small deflection prior 
to the MAP signal (arrows) suggests that myocardial activation preceded myoblast 
activation, which suggests, but does not prove, that myocytes drove the myoblasts. (g, 
h, i) enlargement of the recordings a, e and f, respectively. (j) higher enlargement of 
the recording f/i. 
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Characterization of myoblast primary cultures after lentivirus vector transduction.  
190x254mm (300 x 300 DPI)  
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Figure 3: In vivo Cx43 and Wpre gene expression, following ex vivo lentivirus vector transduction 
and intramyocardial transplantation.  
108x170mm (300 x 300 DPI)  
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Ventricular hyperexcitability of the myocardium after myoblast transplantation.  
190x254mm (300 x 300 DPI)  
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